Back

Discussant review - SEQUOIA­HCM

18 May 2025 (11:19 - 11:22)
Organised by: Logo
Congress Presentation Part of: Hottest trials and trial updates (2) Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Pieter Martens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

20 More presentations in this session

Presentation thumbnail
DIGIT­HF: Baseline characteristics compared to recent trials in heart failure with reduced ejection fraction
Professor U. Bavendiek (Hannover, DE)
Slides Video
Presentation thumbnail
Discussant review - DIGIT­HF
Professor D. van Veldhuisen (Groningen, NL)
Slides Video
Presentation thumbnail
Panel discussion - DIGIT­HF
Video
Presentation thumbnail
CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy
Doctor A. Owens (Philadelphia, US)
Slides Video
Presentation thumbnail
Discussant review - CIRRUS­HCM
Professor I. Olivotto (Florence, IT)
Slides Video

Access the full session

Session thumbnail
Hottest trials and trial updates (2)
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 11:19 CET
You may be interested in
thumbnail
Congress Presentation
Is the patient profile the same in different regions of the globe?
12 May 2024
thumbnail
Congress Session
Precision medicine in hypertrophic cardiomyopathy
30 August 2025
thumbnail
Congress Session
Daily Highlights by the South African Heart Association
25 August 2023
thumbnail
Congress Presentation
Moving towards new trial design for achieving personalised medicine
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources